Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Breast Neoplasms 37 Prostatic Neoplasms 12 Triple Negative Breast Neoplasms 4 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Liver Neoplasms 3 Fibrosis 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3 Carcinoma, Intraductal, Noninfiltrating 3 Uterine Cervical Neoplasms 2 Thyroid Nodule 2 Stomach Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Pleural Effusion, Malignant 2 Neoplasms 2 Mouth Neoplasms 2 Melanoma 2 Lymphoma 2 Lymphedema 2 Leukemia, Myeloid, Acute 2 Leukemia 2 Inflammatory Breast Neoplasms 2 Infertility 2 Hodgkin Disease 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Carcinoma, Medullary 2 Carcinoma, Hepatocellular 2 Anatomic Stage III Breast Cancer AJCC v8 2

Interventions

Echocardiography 4 sacubitril and valsartan sodium hydrate drug combination 3 Standard of Care 3 Nutrition Assessment 3 Exercise 3 Electrocardiography 3 Carvedilol 3 dapagliflozin 2 Surveys and Questionnaires 2 Spironolactone 2 Rituximab 2 Lenalidomide 2 Ivabradine 2 Control Groups 2 Blood Specimen Collection 2 Atorvastatin 2 Adrenergic beta-Antagonists 2 ziprasidone 1 pertuzumab 1 pegfilgrastim 1 obinutuzumab 1 nicotinamide-beta-riboside 1 empagliflozin 1 candesartan 1 acalabrutinib 1 Zolpidem 1 Watchful Waiting 1 Warfarin 1 Vincristine 1 Vecuronium Bromide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Heart Failure × High-Energy Shock Waves × Clear all

NCT02080390 2019-03-01

Strain Imaging in Breast Cancer Patients Receiving Trastuzumab

University of Florida

Heart Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡